HONG KONG — A new system developed by Australian scientists for generating induced multipotent stem (iMS) cells could result in stem cell therapies for regenerating any human tissue becoming available in the near future, with clinical trials slated to begin in orthopedic patients as early as next year, if the new technique first proves safe and effective in mice.